Product Description
Polyethylene glycol 3350 is used to treat occasional constipation. (Sourced from: https://medlineplus.gov/druginfo/meds/a603032.html)
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: Unknown
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Braintree Laboratories
Company Location: Eastern America
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 4: Constipation
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT00153140 |
851-ZCC | P4 |
Completed |
Constipation |
2004-10-01 |
2019-03-21 |
Treatments |
|
NCT00153153 |
851-CR1 | P4 |
Completed |
Constipation |
2004-12-01 |
2019-03-21 |
Treatments |
|
NCT00164125 |
851-CR3 | P4 |
Completed |
Constipation |
2004-11-01 |
2019-03-21 |
Treatments |
|
NCT00153114 |
NCT00153114 | P4 |
Completed |
Constipation |
2004-09-01 |
2019-03-21 |
Treatments |
|
NCT00153127 |
NCT00153127 | P4 |
Completed |
Constipation |
2004-09-01 |
2019-03-21 |
Treatments |
Recent News Events
Date |
Type |
Title |
|---|